MGTX
Price
$8.25
Change
+$1.84 (+28.71%)
Updated
Mar 13 closing price
Capitalization
644.77M
55 days until earnings call
PRQR
Price
$1.74
Change
-$0.11 (-5.95%)
Updated
Mar 13 closing price
Capitalization
184.28M
55 days until earnings call
Ad is loading...

MGTX vs PRQR

Header iconMGTX vs PRQR Comparison
Open Charts MGTX vs PRQRBanner chart's image
MeiraGTx Holdings
Price$8.25
Change+$1.84 (+28.71%)
Volume$6.31M
Capitalization644.77M
ProQR Therapeutics
Price$1.74
Change-$0.11 (-5.95%)
Volume$432.13K
Capitalization184.28M
MGTX vs PRQR Comparison Chart
Loading...
MGTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRQR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MGTX vs. PRQR commentary
Mar 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MGTX is a Hold and PRQR is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Mar 14, 2025
Stock price -- (MGTX: $8.25 vs. PRQR: $1.74)
Brand notoriety: MGTX and PRQR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MGTX: 1387% vs. PRQR: 117%
Market capitalization -- MGTX: $644.77M vs. PRQR: $184.28M
MGTX [@Biotechnology] is valued at $644.77M. PRQR’s [@Biotechnology] market capitalization is $184.28M. The market cap for tickers in the [@Biotechnology] industry ranges from $329.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.29B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MGTX’s FA Score shows that 0 FA rating(s) are green whilePRQR’s FA Score has 0 green FA rating(s).

  • MGTX’s FA Score: 0 green, 5 red.
  • PRQR’s FA Score: 0 green, 5 red.
According to our system of comparison, MGTX is a better buy in the long-term than PRQR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MGTX’s TA Score shows that 6 TA indicator(s) are bullish while PRQR’s TA Score has 5 bullish TA indicator(s).

  • MGTX’s TA Score: 6 bullish, 3 bearish.
  • PRQR’s TA Score: 5 bullish, 6 bearish.
According to our system of comparison, MGTX is a better buy in the short-term than PRQR.

Price Growth

MGTX (@Biotechnology) experienced а +27.71% price change this week, while PRQR (@Biotechnology) price change was -10.31% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.60%. For the same industry, the average monthly price growth was -6.51%, and the average quarterly price growth was -9.04%.

Reported Earning Dates

MGTX is expected to report earnings on May 08, 2025.

PRQR is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (-2.60% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MGTX($645M) has a higher market cap than PRQR($184M). MGTX YTD gains are higher at: 35.468 vs. PRQR (-34.340). PRQR has higher annual earnings (EBITDA): -18.59M vs. MGTX (-61.2M). MGTX has more cash in the bank: 123M vs. PRQR (89.4M). PRQR has less debt than MGTX: PRQR (17.4M) vs MGTX (86.7M). PRQR has higher revenues than MGTX: PRQR (17.9M) vs MGTX (13.9M).
MGTXPRQRMGTX / PRQR
Capitalization645M184M351%
EBITDA-61.2M-18.59M329%
Gain YTD35.468-34.340-103%
P/E RatioN/AN/A-
Revenue13.9M17.9M78%
Total Cash123M89.4M138%
Total Debt86.7M17.4M498%
FUNDAMENTALS RATINGS
MGTX vs PRQR: Fundamental Ratings
MGTX
PRQR
OUTLOOK RATING
1..100
8880
VALUATION
overvalued / fair valued / undervalued
1..100
65
Fair valued
35
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9695
PRICE GROWTH RATING
1..100
4382
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PRQR's Valuation (35) in the Biotechnology industry is in the same range as MGTX (65). This means that PRQR’s stock grew similarly to MGTX’s over the last 12 months.

PRQR's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as MGTX (100). This means that PRQR’s stock grew similarly to MGTX’s over the last 12 months.

PRQR's SMR Rating (95) in the Biotechnology industry is in the same range as MGTX (96). This means that PRQR’s stock grew similarly to MGTX’s over the last 12 months.

MGTX's Price Growth Rating (43) in the Biotechnology industry is somewhat better than the same rating for PRQR (82). This means that MGTX’s stock grew somewhat faster than PRQR’s over the last 12 months.

MGTX's P/E Growth Rating (100) in the Biotechnology industry is in the same range as PRQR (100). This means that MGTX’s stock grew similarly to PRQR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MGTXPRQR
RSI
ODDS (%)
Bearish Trend 1 day ago
84%
Bullish Trend 1 day ago
87%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
89%
Bullish Trend 1 day ago
85%
Momentum
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bullish Trend 1 day ago
89%
Bearish Trend 1 day ago
84%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 1 day ago
82%
Advances
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 24 days ago
86%
Declines
ODDS (%)
Bearish Trend 5 days ago
83%
Bearish Trend 5 days ago
83%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
82%
Bullish Trend 1 day ago
82%
Aroon
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
85%
View a ticker or compare two or three
Ad is loading...
MGTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRQR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FRIQX12.10N/A
N/A
Fidelity Advisor Real Estate Income M
NELCX48.50N/A
N/A
Nuveen Equity Long/Short C
MNHCX24.55N/A
N/A
Manning & Napier Pro-Blend Max Term L
JEMQX9.39N/A
N/A
JHancock Emerging Markets Equity A
RCEAX10.10N/A
N/A
RBC China Equity A

MGTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MGTX has been loosely correlated with AURA. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if MGTX jumps, then AURA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MGTX
1D Price
Change %
MGTX100%
+28.71%
AURA - MGTX
48%
Loosely correlated
-3.07%
BEAM - MGTX
48%
Loosely correlated
-8.61%
ABOS - MGTX
47%
Loosely correlated
-4.69%
CRBU - MGTX
46%
Loosely correlated
-7.03%
TRDA - MGTX
45%
Loosely correlated
-3.57%
More

PRQR and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRQR has been loosely correlated with KRRO. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if PRQR jumps, then KRRO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRQR
1D Price
Change %
PRQR100%
-5.95%
KRRO - PRQR
58%
Loosely correlated
+10.24%
WVE - PRQR
53%
Loosely correlated
-5.00%
ATNF - PRQR
52%
Loosely correlated
-7.69%
ENVB - PRQR
43%
Loosely correlated
+1.86%
MGTX - PRQR
33%
Poorly correlated
+28.71%
More